Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Acres

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|November 6, 2007
Cancer immunotherapy: phase II clinical studies with TG4010 (MVA-MUC1-IL2)Bruce Acres
Bulletin Du Cancer|March 21, 2007
[MUC1, a therapeutic target in oncology]Jean-Marc Limacher, Bruce Acres
Expert Review of Vaccines|August 25, 2005
MUC1 as a target antigen for cancer immunotherapyBruce Acres, Jean-Marc Limacher
Expert Review of Vaccines|September 5, 2008
Clinical development of MVA-based therapeutic cancer vaccinesBruce Acres, Jean-Yves Bonnefoy
Discovery Medicine|August 14, 2010
Gene-based cancer immunotherapy and vaccinesBruce Acres, Patrick Squiban, Margaret Liu
Current Topics in Microbiology and Immunology|February 23, 2015
Targeted Immunotherapy Designed to Treat MUC1-Expressing Solid TumourBruce Acres, Gisele Lacoste, Jean-Marc Limacher
Current Gene Therapy|July 12, 2002
Improvement of adoptive cellular immunotherapy of human cancer using ex-vivo gene transferStephane Paul, Bastien Calmels, R Bruce Acres
Current Opinion in Drug Discovery & Development|April 18, 2007
Discovery and development of therapeutic cancer vaccinesBruce Acres, Jean-Marc Limacher, Jeanoy Bonnefoy
Cancer Immunology, Immunotherapy : CII|December 16, 2004
Secretomers as a new tool for the monitoring of CTL responsesBastien Calmels, Stephane Paul, Christelle Ziller, et al.
Idrugs : the Investigational Drugs Journal|May 10, 2007
Cancer vaccines: challenges and outlook in the fieldStéphane Paul, Bruce Acres, Jean-Marc Limacher, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|November 6, 2007
Cancer immunotherapy: phase II clinical studies with TG4010 (MVA-MUC1-IL2)Bruce Acres
Bulletin Du Cancer|March 21, 2007
[MUC1, a therapeutic target in oncology]Jean-Marc Limacher, Bruce Acres
Expert Review of Vaccines|August 25, 2005
MUC1 as a target antigen for cancer immunotherapyBruce Acres, Jean-Marc Limacher
Expert Review of Vaccines|September 5, 2008
Clinical development of MVA-based therapeutic cancer vaccinesBruce Acres, Jean-Yves Bonnefoy
Discovery Medicine|August 14, 2010
Gene-based cancer immunotherapy and vaccinesBruce Acres, Patrick Squiban, Margaret Liu
Current Topics in Microbiology and Immunology|February 23, 2015
Targeted Immunotherapy Designed to Treat MUC1-Expressing Solid TumourBruce Acres, Gisele Lacoste, Jean-Marc Limacher
Current Gene Therapy|July 12, 2002
Improvement of adoptive cellular immunotherapy of human cancer using ex-vivo gene transferStephane Paul, Bastien Calmels, R Bruce Acres
Current Opinion in Drug Discovery & Development|April 18, 2007
Discovery and development of therapeutic cancer vaccinesBruce Acres, Jean-Marc Limacher, Jeanoy Bonnefoy
Cancer Immunology, Immunotherapy : CII|December 16, 2004
Secretomers as a new tool for the monitoring of CTL responsesBastien Calmels, Stephane Paul, Christelle Ziller, et al.
Idrugs : the Investigational Drugs Journal|May 10, 2007
Cancer vaccines: challenges and outlook in the fieldStéphane Paul, Bruce Acres, Jean-Marc Limacher, et al.
Pageof 3